Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China

Chinese Medical Journal

Volumn 122, Issue 1, 2009, Pages 5-9

  Bai, Li ^a   Feng, Zhen Ru ^a   Lu, Hai Ying ^a   Li, Wen Gang ^a   Yu, Min ^a   Xu, Xiao Yuan ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Autoantibodies; Autoimmune; Chronic; Hepatitis; Hepatitis C

Indexed keywords

ALPHA INTERFERON; ANTINUCLEAR ANTIBODY; MICROSOME ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; AGE; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; CHILD; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOFLUORESCENCE TEST; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; CHINA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 60649115479     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.01.002     Document Type: Article

References (39)

1. Lenzi M. Autoimmune hepatitis and hepatitis C virus infection. FEMS Microbiol Rev 1994; 14: 247-252.
2. Cassani F, Cataleta M, Valentini P, Muratori P, Giostra F, Francesconi R, et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 1997; 26: 561-566.
3. Ichijo T, Kiyosawa K. Hepatitis C virus infection and autoimmunity. J Gastroenterol Hepatol 2002; 17: 813-815.
4. Vento S, Cainelli F. Is there a role for viruses in triggering autoimmune hepatitis? Autoimmun Rev 2004; 3: 61-69.
5. Bortolotti F, Vajro P, Balli F, Giacchino R, Crivellaro C, Barbera C, et al. Non-organ specific autoantibodies in children with chronic hepatitis C. J Hepatol 1996; 25: 614-620.
6. Lenzi M, Bellentani S, Saccoccio G, Muratori P, Masutti F, Muratori L, et al. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort. Gut 1999; 45: 435-441.
7. Muratori P, Muratori L, Stroffolini T, Pappas G, Terlizzi P, Ferrari R, et al. Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population. Clin Exp Immunol 2003; 131: 118-121.
8. Wasmuth HE, Stolte C, Geier A, Dietrich CG, Gartung C, Lorenzen J, et al. The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C. BMC Infect Dis 2004; 4: 4.
9. Muratori P, Muratori L, Guidi M, Granito A, Susca M, Lenzi M, et al. Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C. Clin Infect Dis 2005; 40: 501-507.
10. Gatselis NK, Georgiadou SP, Tassopoulos N, Zachou K, Liaskos C, Hatzakis A, et al. Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: A pilot study. World J Gastroenterol 2005; 11: 482-487.
11. Rigopoulou EI, Mytilinaiou M, Romanidou O, Liaskos C, Dalekos GN. Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis. J Autoimmun Dis 2007; 4: 2.
12. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938.
13. Obermayer-Straub P, Strassburg CP, Manns MP. Autoimmune hepatitis. J Hepatol 2000; 32 Suppl 1: s181-s197.
14. Zachou K, Rigopoulou E, Dalekos GN. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease. J Autoimmune Dis 2004; 1: 2.
15. Gregorio GV, Pensati P, Iorio R, Vegnente A, Mieli-Vergani G, Vergani D. Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 1998; 112: 471-476.
16. Monti V, Aghemo A, Rumi MG, Donato MF, Del Ninno E, Colombo M. The prevalence, clinical features and response to antiviral therapy of patients with chronic hepatitis C who are seropositive for liver-kidney microsome type 1 antibodies. Antivir Ther 2005; 10: 715-720.
17. Nishioka M, Morshed SA, Kono K, Himoto T, Parveen S, Arima K, et al. Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C. J Hepatol 1997; 26: 992-1000.
18. Drygiannakis D, Lionis C, Drygiannakis I, Pappas G, Kouroumalis E. Low prevalence of liver-kidney microsomal autoantibodies of type 1 (LKM1) in hepatitis C seropositive subjects on Crete, Greece. BMC Gastroenterol 2001; 1: 4.
19. Dalekos GN, Makri E, Loges S, Obermayer-Straub P, Zachou K, Tsikrikas T, et al. Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece. Eur J Gastroenterol Hepatol 2002; 14: 35-42.
20. Leri O, Paparo Barbaro S, Sinopoli MT, Marcelli V, De Rosa FG, De Luca D. Type 2 autoimmune hepatitis and hepatitis C viraemia. Riv Eur Sci Med Farmacol 1996; 18: 3-6.
21. Hepatotogy Branch, Infectious and Parasitology Branch, Chinese Medical Association. Guideline of prevention and treatment of hepatitis C. Natl Med J China (Chin) 2004; 84: 775-780.
22. Du SC, Tao QM, Zhu L. Typing on 5′-terminal noncoding region of hepatitis C virus genome with restrict endonuclease. Natl Med J China (Chin) 1993; 73: 7-9.
23. Hepatotogy Branch, Infectious and Parasitology Branch, Chinese Medical Association. Guidelines for the prevention and treatment of viral hepatitis. Chin J Intern Med (Chin) 2001; 40: 62-68.
24. Ren SH, Zhang YL, Zou HX. Detection of auto-antibodies in HCV carriers and its significance. Acta Acad Med Qingdao Univ (Chin) 2002; 38: 60-61.
25. Cao HJ, Li SJ, Wang X, Wang GJ, Wang XY. Detection of autoantibodies in liver diseases and its clinical application. J Dalian Med Univ (Chin) 2006; 28: 60-63.
26. Huang JQ, Zheng ZX, Huang TJ, Yu HJ, Xiao F, Ning Q. Detection of autoantibodies in chronic liver disease and its correlation with autoimmune liver diseases. Acta Med Univ Sci Technol Huazhong (Chin) 2006; 35: 195-198.
27. Czaja AJ, Taswell HF, Rakela J, Schimek C. Frequency of antibody to hepatitis C virus in asymptomatic HBsAg-negative chronic active hepatitis. J Hepatol 1992; 14: 88-93.
28. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995; 21: 613-619.
29. Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia MB, Andre C, et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995; 122: 169-173.
30. Naparstek Y, Plotz PH. The role of autoantibodies in autoimmune disease. Annu Rev Immunol 1993; 11: 79-104.
31. Yee LJ, Kelleher P, Goldin RD, Marshall S, Thomas HC, Alberti A, et al. Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance. J Viral Hepat 2004; 11: 459-464.
32. Hsieh MY, Dai CY, Lee LP, Huang JF, Tsai WC, Hou NJ, et al. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C. J Clin Pathol 2008; 61: 333-337.
33. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001; 2: 777-780.
34. Vento S, Cainelli F, Renzini C, Concia E. Autoimmune hepatitis type 2 induced by HCV and persisting after viral clearance. Lancet 1997; 350: 1298-1299.
35. Zhao CY, Wang LS, Zhang JG, Li JY, Pang Y. Detection of autoantibodies in patients with chronic hepatitis C. Chin J Clin Hepatol (Chin) 1997; 13: 78-79.
36. Giostra F, Manzin A, Lenzi M, Francesconi R, Solforosi L, Manotti P, et al. Low hepatitis C viremia levels in patients with anti-liver/kidney microsomal antibody type 1 positive chronic hepatitis. J Hepatol 1996; 25: 433-438.
37. Wei SH, Liu SL, Zhang LJ, Xu SJ, Guo L. Study on relationship between HCV infection and autoimmune. J Immunol (Chin) 2003; 19: 406-407.
38. Iijima Y, Kato T, Miyakawa H, Ogino M, Mizuno M, Sugihara K, et al. Effect of interferon therapy on Japanese chronic hepatitis C virus patients with anti-liver/kidney microsome autoantibody type 1. J Gastroenterol Hepatol 2001; 16: 782-788.
39. Stroffolini T, Colloredo G, Gaeta GB, Sonzogni A, Angeletti S, Marignani M, et al. Does an 'autoimmune' profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey. J Viral Hepat 2004; 11: 257-262.